⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
ARGX News
argenx SE American Depositary Shares
argenx Announces Positive Topline Results from Phase 3 ALKIVIA Trial of Efgartigimod in Autoimmune Myositis
globenewswire.com
ARGX
Forte Biosciences Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Forte Biosciences, Inc. - FBRX
businesswire.com
ARGX
FBRX
argenx Announces Commencement of Tender Offer to Acquire Forte Biosciences, Inc.
globenewswire.com
ARGX
FBRX
argenx Announces Commencement of Tender Offer to Acquire Forte Biosciences, Inc.
globenewswire.com
ARGX
FBRX
argenx announces Extraordinary General Meeting of Shareholders on September 17, 2026
globenewswire.com
ARGX
Forte Biosciences Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Forte Biosciences, Inc. - FBRX
businesswire.com
ARGX
FBRX
argenx to Acquire Forte Biosciences, Inc., Adding First-in-Class Anti-CD122 Antibody, FB102, to Its Immunology Pipeline
businesswire.com
ARGX
FBRX
argenx to Acquire Forte Biosciences, Inc., Adding First-in-Class anti-CD122 Antibody, FB102, to its Immunology Pipeline
globenewswire.com
ARGX
FBRX
argenx Reports Half Year 2026 Financial Results and Provides Second Quarter Business Update
globenewswire.com
ARGX
argenx to Report Half Year 2026 Financial Results and Second Quarter Business Update on July 23, 2026
globenewswire.com
ARGX